Prof. Florent Malard, Hôpital Saint-Antoine, Paris, France
Prof. Yishan Ye, The First Affiliated Hospital, Zhejiang University School of Medicine, China
Prof. Ye and Prof. Malard discussed how to optimize the HSCT clinical treatment system for older or comorbid patients, with a focus on integrating bridging strategies based on targeted therapies and cellular therapies. They explored how these approaches may help overcome treatment resistance and improve long-term survival in this challenging population.